Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dharma Bioscience
Miami, Florida, United Statesdharmabioscience.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Dharma Bioscience develops a non-invasive miRNA-based therapy for osteoarthritis. Their approach uses modified microRNAs delivered locally via lipid nanoparticles to stimulate chondrocyte restoration and cartilage regeneration, aiming to address the root cause of osteoarthritis. No published clinical results yet; appears to be in preclinical development.
- Therapeutic areas
- Rheumatology
- Modalities
- microRNA (miRNA) therapeutics, delivered via lipid nanoparticles
- Industry
- Biotech
02
Partnerships
Eretz.bio accelerator program participant in late 2024/early 2025
Beyond the preview
Go deeper on Dharma Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dharma Bioscience.